Icon

LUTATHERA (nda208700)- (10mCi/ML)

LUTETIUM LU 177 DOTATATE AAA USA INC
10mCi/ML
Yes No
2039-Jan-25 2023-Jan-26
None None
None No
LUTATHERA is a radiolabeled somatostatin analog indicated for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors in adults.
0 0 0
Total Other Developers None
Drugs with Suitability No
10mCi/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.